Govt to announce regulatory guidelines for OTC drugs: Dy Drug Controller, MoH&FW
The consultative committee will give its recommendations to the DTAB, which will be submitted to the government to amend the rules…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pharma regulations
US FDA warns against co-administration of remdesivir and chloroquine or HCQ
The drug regulator informs that this may reduce the antiviral activity of remdesivir and lessen the effectiveness of COVID-19…
Lupin to approach USFDA for reinspection of key plants in next few months
Reportedly, regulatory action by the USFDA has impacted several new approvals, thus affecting the company's business in various…
Industry welcomes draft New Drugs and Clinical Trials (Amendment) Rules
Recommend measures for more clarity and impact
AYUSH Ministry to act against misleading COVID-19 products
Industry experts express the need for amendments and clarity in existing regulations for AYUSH products in the larger public…
Ministry of Health publishes draft New Drugs and Clinical Trials (Amendment) Rules
The move is aimed at facilitating the availability of new drugs which are in Phase-III clinical trials (human trials) for…
Hand sanitisers to be sold in licensed selling premises only: Maharashtra FDA
Earlier, Hindustan Unilever has sought clarification on the matter from Maharashtra FDA
FICCI submits recommendations to government for regulatory reforms in pharma
The recommendations comprise improvement proposals for new drug registrations; animal toxicity and testing, clinical trials; and…
High-level panel to recommend reforms in India’s drug regulations
The panel, chaired by Rajesh Bhushan, the OSD to the Union Health Minister, comprises top drug and vaccine entrepreneurs as well…
Industry seeks clarity in regulations for sale of hand sanitisers
Opposing views prevail on the inclusion of hand sanitisers under Schedule K of Drugs and Cosmetics Rules, 1945